Skip to main content
. Author manuscript; available in PMC: 2011 May 7.
Published in final edited form as: Vaccine. 2010 Mar 28;28(21):3672–3678. doi: 10.1016/j.vaccine.2010.03.022

Fig. 2. HSMBC frequencies (spot forming cells per million PBMC) in HIV uninfected and HIV infected study patients stratified as high titer responders (HBsAb >1000 mIU/ml) or low titer responders (HBsAb <1000 mIU/ml) at study week 28.

Fig. 2